Hair Growth (Androgenetic Alopecia)
Source: Multiple RCTs / FDA Clearances
Protocol for treating androgenetic alopecia (pattern hair loss) in both men and women using red wavelengths. This is one of the most well-researched applications of photobiomodulation, with multiple FDA-cleared devices available specifically for hair growth.
Protocol Parameters
| Condition | Androgenetic Alopecia |
| Wavelengths | 630nm, 650nm, 660nm |
| Dosage | 3-6 J/cm² |
| Irradiance | 10-50 mW/cm² |
| Duration | 15-25 minutes |
| Frequency | Every other day (3-4x per week) |
| Body Zone | scalp |
| Evidence Level | Strong |
Mechanism of Action
Red light stimulates dermal papilla cells, prolongs the anagen (growth) phase of the hair cycle, increases local blood flow to follicles, and reduces inflammation around miniaturizing follicles. It upregulates growth factors including VEGF, HGF, and IGF-1 while reducing DHT-related inflammatory damage.
Key Studies
- Lanzafame et al. (2013) - 655nm LED for male pattern hair loss
- Kim et al. (2013) - 655nm laser for female pattern hair loss
- Jimenez et al. (2014) - Multicenter RCT of laser hair growth device
- Afifi et al. (2017) - Systematic review of PBM for hair loss
Treatment Tips
- *Consistency is critical - minimum 4-6 months before visible results
- *Every-other-day treatment is better than daily (biphasic response)
- *Cap/helmet devices ensure consistent scalp coverage
- *Can be combined with minoxidil and/or finasteride
- *Photograph progress monthly for objective tracking
Contraindications
- !Alopecia areata (different mechanism, limited evidence)
- !Scarring alopecia (follicles destroyed)
- !Active scalp infection or psoriasis flare
Related Body Zone
Scalp & Hair Zone Guide
The scalp is treated primarily for hair loss conditions, particularly androgenetic alopecia (pattern baldness). Red light at 630-660nm stimulates hair...
Research Basis
This content is informed by 47+ published peer-reviewed studies on photobiomodulation.
RedLightOS Research Team
Photobiomodulation Research
The RedLightOS team reviews over 9,500 published photobiomodulation studies to deliver evidence-based red light therapy guidance.
Reviewed by RedLightOS Research Team. Last reviewed: . Based on published photobiomodulation research. For educational purposes only — not a substitute for professional medical advice. See our methodology.
Medical Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Red light therapy devices are wellness devices and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.